Need for repeat surgery · vaginal prolapse
Transvaginal permanent mesh may leads to higher repeat surgery (0.5 to 7 years) compared with native tissue repair (low certainty).
1 finding from 1 review
Requirement for further surgery for treatment failure · heavy menstrual bleeding
1 finding from 1 review
Requirement for further surgery for treatment failure within 1 year after surgery · HMB
1 finding from 1 review
Requirement for further surgery for treatment failure within 1 year after surgery · heavy menstrual bleeding
Endometrial resection or ablation probably leads to higher requirement for further surgery for treatment failure within 1 year… compared with minimally invasive hysterectomy (moderate certainty).
1 finding from 1 review
Requirement for additional (surgical) interventions · heavy menstrual bleeding
Overall analyses: second‐generation endometrial ablation showed no clear difference in requirement for additional surgery compared with first‐generation endometrial ablation (low certainty).
1 finding from 1 review
Surgery‐related adverse events: intraoperative complications · premenopausal women undergoing hysterectomy for benign gynaecological indications
It is very uncertain whether hysterectomy with opportunistic salpingectomy changes surgery‐related adverse events: intraoperative complications compared with hysterectomy without opportunistic salpingectomy (very low certainty).
1 finding from 1 review
Surgery‐related adverse events: short‐term postoperative complications · premenopausal women undergoing hysterectomy for benign gynaecological indications
It is very uncertain whether hysterectomy with opportunistic salpingectomy changes surgery‐related adverse events: short‐term postoperative complications compared with hysterectomy without opportunistic salpingectomy (very low certainty).
1 finding from 1 review
Operating time · women with uterine fibroids
Misoprostol showed no clear difference in duration of surgery (min) Operative time compared with placebo to reduce blood loss during myomectomy (low certainty).
1 finding from 1 review
Operative time · women with uterine fibroids
Vasopressin showed no clear difference in duration of surgery Operative time compared with placebo to reduce blood loss during myomectomy (moderate certainty).
1 finding from 1 review
Operating time · women with uterine fibroids
Bupivicaine plus epinephrine showed no clear difference in duration of surgery (min) Operative time compared with placebo to reduce blood loss during myomectomy (low certainty).
1 finding from 1 review
Operating time · women with uterine fibroids
It is very uncertain whether peri‐cervical tourniquet changes duration of surgery (min) Operative time compared with no treatment to reduce blood loss during myomectomy (very low certainty).
1 finding from 1 review
Operating time · women with uterine fibroids
Gelatin‐thrombin matrix may leads to higher duration of surgery (min) Operative time compared with placebo or no treatment to reduce blood loss during myomectomy (low certainty).
1 finding from 1 review
Operating time · women with uterine fibroids
Ascorbic acid showed no clear difference in duration of surgery (min) Operative time compared with no treatment to reduce blood loss during myomectomy (low certainty).
1 finding from 1 review
Intervention not reported
Prevalence of stress urinary incontinence within 2 years post surgery [ · Women requiring hysterectomy for benign conditions
The intervention showed no clear difference in prevalence of stress urinary incontinence within 2 years post… (moderate certainty).
1 finding from 1 review
OR 1.45 [0.85, 2.47]
955 participants
Moderate
Intervention not reported
Prevalence of constipation within 2 years post surgery [ · Women requiring hysterectomy for benign conditions
The intervention showed no clear difference in prevalence of constipation within 2 years post surgery [ (low certainty).
1 finding from 1 review
OR 0.8 [0.49, 1.31]
555 participants
Low
Intervention not reported
Satisfaction with sex within 2 years post surgery [ · Women requiring hysterectomy for benign conditions
The intervention showed no clear difference in satisfaction with sex within 2 years post surgery [ (low certainty).
1 finding from 1 review
OR 1.04 [0.68, 1.59]
454 participants
Low
Overall pain at 12 months  · Patients with symptomatic endometriosis following surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Chronic pelvic pain at 12 months  · Patients with symptomatic endometriosis following surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Dysmenorrhoea at 12 months  · Patients with symptomatic endometriosis following surgery
1 finding from 1 review
no estimate extracted
95 participants
Very low
Improvement of the most troublesome symptom at 12 months  · Patients with symptomatic endometriosis following surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found